BSX

BSX

USD

Boston Scientific Corporation Common Stock

$98.840-0.140 (-0.141%)

السعر في الوقت الحقيقي

Healthcare
الأجهزة الطبية
الولايات المتحدة

مخطط الأسعار

Loading Chart...

المقاييس الرئيسية

مقاييس السوق
أساسيات الشركة
إحصاءات التداول

مقاييس السوق

الافتتاح

$98.980

الأعلى

$99.310

الأدنى

$98.250

الحجم

4.81M

أساسيات الشركة

القيمة السوقية

146.5B

الصناعة

الأجهزة الطبية

البلد

United States

إحصاءات التداول

متوسط الحجم

8.69M

البورصة

NYQ

العملة

USD

نطاق 52 أسبوعاً

الأدنى $84.13الحالي $98.840الأعلى $109.5

أخبار ذات صلة

Analyst Upgrades

Truist Securities Maintains Buy on Boston Scientific, Raises Price Target to $130

Truist Securities analyst Richard Newitter maintains Boston Scientific with a Buy and raises the price target from $129 to $130.

عرض المزيد
Truist Securities Maintains Buy on Boston Scientific, Raises Price Target to $130
Analyst Upgrades

Wells Fargo Maintains Overweight on Boston Scientific, Raises Price Target to $125

Wells Fargo analyst Larry Biegelsen maintains Boston Scientific with a Overweight and raises the price target from $124 to $125.

عرض المزيد
Wells Fargo Maintains Overweight on Boston Scientific, Raises Price Target to $125
Analyst Upgrades

Morgan Stanley Maintains Overweight on Boston Scientific, Raises Price Target to $130

Morgan Stanley analyst Patrick Wood maintains Boston Scientific with a Overweight and raises the price target from $125 to $130.

عرض المزيد
Morgan Stanley Maintains Overweight on Boston Scientific, Raises Price Target to $130
Analyst Upgrades

BTIG Reiterates Buy on Boston Scientific, Maintains $132 Price Target

BTIG analyst Marie Thibault reiterates Boston Scientific with a Buy and maintains $132 price target.

عرض المزيد
BTIG Reiterates Buy on Boston Scientific, Maintains $132 Price Target
Analyst Upgrades

Boston Scientific Gains Momentum As Growth Broadens, Goldman Sachs Says

Goldman Sachs analyst David Roman reiterated a Buy rating and $120 price target for Boston Scientific after strong Q3 results and raised guidance.

عرض المزيد
Boston Scientific Gains Momentum As Growth Broadens, Goldman Sachs Says
PR Newswire

Boston Scientific announces results for third quarter 2025

Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.065 billion during the third quarter of 2025, growing 20.3 percent on a reported...

Analyst Upgrades

Evercore ISI Group Maintains Outperform on Boston Scientific, Lowers Price Target to $110

Evercore ISI Group analyst Vijay Kumar maintains Boston Scientific with a Outperform and lowers the price target from $115 to $110.

ابق على اطلاع

تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.